FI962236A - Heterosykliset bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina - Google Patents

Heterosykliset bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina Download PDF

Info

Publication number
FI962236A
FI962236A FI962236A FI962236A FI962236A FI 962236 A FI962236 A FI 962236A FI 962236 A FI962236 A FI 962236A FI 962236 A FI962236 A FI 962236A FI 962236 A FI962236 A FI 962236A
Authority
FI
Finland
Prior art keywords
inhibitors
pct
function
sec
heterocyclic
Prior art date
Application number
FI962236A
Other languages
English (en)
Swedish (sv)
Other versions
FI113368B (fi
FI962236A0 (fi
Inventor
George Ku
Boyd Lynn Harrison
David M Stemerick
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI962236A publication Critical patent/FI962236A/fi
Publication of FI962236A0 publication Critical patent/FI962236A0/fi
Application granted granted Critical
Publication of FI113368B publication Critical patent/FI113368B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962236A 1993-11-29 1996-05-28 Menetelmä terapeuttisesti aktiivisten 2-(karboksi tai karbamidi)-4-sulfonyyli-(kromeenien tai tiokromeenien valmistamiseksi FI113368B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15866193A 1993-11-29 1993-11-29
US15866193 1993-11-29
US9412575 1994-11-03
PCT/US1994/012575 WO1995014670A1 (en) 1993-11-29 1994-11-03 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action

Publications (3)

Publication Number Publication Date
FI962236A true FI962236A (fi) 1996-05-28
FI962236A0 FI962236A0 (fi) 1996-05-28
FI113368B FI113368B (fi) 2004-04-15

Family

ID=22569128

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962236A FI113368B (fi) 1993-11-29 1996-05-28 Menetelmä terapeuttisesti aktiivisten 2-(karboksi tai karbamidi)-4-sulfonyyli-(kromeenien tai tiokromeenien valmistamiseksi

Country Status (20)

Country Link
US (1) US5668143A (fi)
EP (1) EP0731792B1 (fi)
JP (1) JP3612073B2 (fi)
KR (1) KR100351884B1 (fi)
CN (1) CN1045596C (fi)
AT (1) ATE176225T1 (fi)
AU (1) AU682736B2 (fi)
CA (1) CA2177146C (fi)
DE (1) DE69416324T2 (fi)
DK (1) DK0731792T3 (fi)
ES (1) ES2129794T3 (fi)
FI (1) FI113368B (fi)
GR (1) GR3029485T3 (fi)
HU (1) HU222819B1 (fi)
IL (1) IL111774A (fi)
NO (1) NO306158B1 (fi)
NZ (1) NZ276570A (fi)
TW (1) TW281671B (fi)
WO (1) WO1995014670A1 (fi)
ZA (1) ZA949301B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044116C (zh) * 1993-11-29 1999-07-14 默里尔药物公司 用作il－1作用抑制剂的苯磺酰亚胺衍生物及其用途
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
AU2002345796A1 (en) * 2001-06-26 2003-03-03 Beth Israel Deaconess Medical Center Compositions and methods for inhibiting platelet activation and thrombosis
KR100687522B1 (ko) * 2005-05-28 2007-02-27 한국화학연구원 2,2-디메틸-3-에스테르-4-알콕시-6-알킬 아미노벤조피란 유도체를 유효성분으로 함유하는 pge2 활성에 관련된 염증질환 치료제
PL2771180T3 (pl) 2011-10-28 2016-12-30 Sposób wytwarzania ultralekkich struktur tekturowych mających znaczną stabilność mechaniczną

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
ATE137225T1 (de) * 1991-02-27 1996-05-15 Merrell Pharma Inc Dihydrochinolin nmda antagonisten
JPH05331169A (ja) * 1992-05-26 1993-12-14 Sumitomo Pharmaceut Co Ltd ベンゾナフチリジン誘導体

Also Published As

Publication number Publication date
CA2177146C (en) 1999-07-06
AU682736B2 (en) 1997-10-16
JPH09506344A (ja) 1997-06-24
CA2177146A1 (en) 1995-06-01
DE69416324D1 (de) 1999-03-11
WO1995014670A1 (en) 1995-06-01
CN1045596C (zh) 1999-10-13
CN1136312A (zh) 1996-11-20
ATE176225T1 (de) 1999-02-15
ES2129794T3 (es) 1999-06-16
EP0731792A1 (en) 1996-09-18
NZ276570A (en) 2001-02-23
DE69416324T2 (de) 1999-06-10
US5668143A (en) 1997-09-16
IL111774A (en) 1999-11-30
AU1086895A (en) 1995-06-13
ZA949301B (en) 1995-08-07
TW281671B (fi) 1996-07-21
DK0731792T3 (da) 1999-09-13
NO962156D0 (no) 1996-05-28
KR100351884B1 (ko) 2002-12-31
EP0731792B1 (en) 1999-01-27
FI113368B (fi) 2004-04-15
HU222819B1 (hu) 2003-11-28
HUT76272A (en) 1997-07-28
FI962236A0 (fi) 1996-05-28
JP3612073B2 (ja) 2005-01-19
GR3029485T3 (en) 1999-05-28
NO306158B1 (no) 1999-09-27
HU9601434D0 (en) 1996-07-29
IL111774A0 (en) 1995-01-24
NO962156L (no) 1996-05-28

Similar Documents

Publication Publication Date Title
DK0554247T3 (da) Neurobeskyttende indolon og beslægtede derivater
BR9407239A (pt) Azadioxacicloalquenos substituídos
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
FI962235A0 (fi) Uudet bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
FI962236A (fi) Heterosykliset bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina
DE69418035T2 (de) Hiv-proteaseinhibitoren
NO962285D0 (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
BR9603430A (pt) Composições pesticidas
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit

Legal Events

Date Code Title Description
MA Patent expired